In November 2024, headlines across the UK and US media brought a surprising twist to the winter healthcare conversation. The US Food and Drug Administration (FDA) announced a proposal to withdraw certain cold and flu medications specifically those containing phenylephrine from pharmacy shelves. The rationale? Mounting evidence suggesting that phenylephrine, a decongestant used in many…
